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Background 
T he scope of surgery in the treatment of breast cancer is 
currently undergoing reassessment and close scrutiny. 
Halsted introduced the standard radical mastectomy in 
1894 (1), responding to the need for an effective pro-
cedure to treat patients with large and locally advanced 
breast carcinomas. The rationale for the operation was 
based on the concept that cancer extends to the sur-
rounding tissues and the regional lymph nodes in an 
orderly fashion. Accordingly, resection of the organ of 
or ig in, the adjacent tissues, and neighboring lymph 
nodes would constitute maximum effective local-re-
gional treatment and would assure best chances for cure. 
The Halsted radical mastectomy retained its primary 
role in the treatment of breast cancer at its early and 
curable stages for the fol lowing 75 years, and it continues 
to prevail to date. The concept found wide appeal and 
became a blueprint for curative cancer operations for 
many sites. However, early enthusiasm was tempered by 
the realization that, in some instances, the disease 
recurred at the local and regional level, and, in others, 
patients died f rom distant metastases with no evidence 
of local-regional recurrence. Recognizing the physical 
and the emotional impact of mastectomy on women and 
the futi l i ty of its use in instances of predestined failure, 
efforts were made to select groups of patients for whom 
it was curative. Thus, through detailed analysis of clinical 
and histopathological information, the limitations of 
radical mastectomy were better def ined. "Criteria of 
Operabi l i ty" (2) were developed, and the selection 
process was refined by better clinical and paraclinical 
assessment, tr iple biopsy, and other approaches. Among 
surgeons, the extent and technical aspects of the op-
eration were widely debated. 
Important steps in the evolut ion of radical mas-
tectomy, its scope and its l imitations, were best sum-
marized by Haagensen, its main proponent, in the 
Heath Memorial Lecture in 1968 (3). In that review, 
Haagensen emphasized that by meticulous selection of 
patients with early, curable breast cancer, 70% of 402 
patients whom he treated personally by standard radical 
mastectomies were alive ten years later. Only 6.7% 
developed chest wall recurrence, and no recurrences in 
the axilla were found. He also pointed out that when the 
size of the primary tumor increased, the frequency of 
axillary node metastases was higher, and the survival at 
five and ten years was lower. 
In the 1950s, debate among surgeons centered on 
three main areas. One area was the extent of the 
operation necessary to assure local-regional control and 
to improve the chances for cure. A bi-directional chal-
lenge developed in that regard. Al though the Halsted 
radical mastectomy was by then accepted as the standard 
surgical procedure (3), a modif ied version of the pro-
cedure was introduced by Patey and Dyson under the 
term "mod i f i ed radical mastectomy" (4). This pro-
cedure was intended to accomplish the same objective 
as the standard radical mastectomy while preserving the 
pectoralis major muscle. The advantage was less chest 
wall deformity, better shoulder and arm funct ion, and a 
better bed for skin grafting, if such became necessary. 
Auchinclos (5) and Madden (6) introduced further modi-
fications of the modi f ied, which advocated preservation 
of the pectoralis minor muscle as wel l . This latter 
modif icat ion heightened the arguments among sur-
geons, as it was perceived to limit the extent and 
thoroughness of the axillary node dissection, thus com-
promising the regional effectiveness of the operation. By 
1980, however, most surgeons in the United States 
adopted modif ied radical mastectomy as the procedure 
of choice to treat early breast cancer, and its extent 
depended on personal preference rather than on ob-
jective criteria. 
While debate about the modif ied mastectomy went 
on for many years, equally as important was the effort to 
extend the scope of the Halsted radical mastectomy in 
order to remove the internal mammary lymph nodes, a 
nodal group considered to be at risk for early metastases 
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in cancers located at the central or median sectors o f the 
breast. Proponents of this extended approach (7) have 
shown improved ten-year results of survival and local-
regional control wi th low mortality and morbidi ty. 
However, whi le this advantage was evident in two 
personal series (7,8), the results have not been statistically 
substantiated on a prospective trial basis (9). Because of 
its complex technical nature, the higher incidence of 
complications, and the lack of clear-cut superiority of its 
results, extended radical mastectomy has receiveci only 
l imited acceptance (8). 
The second of the three issues, which involved sur-
geons and nonsurgeons alike, challenged the "mech-
anistic" point of view implicit in the Halstedian approach 
with an alternative point of view. In this approach, breast 
cancer is viewed f rom a broad biological perspective as a 
systemic disease in need of systemic thearpy (10). This 
approach recognizes the importance of specific risk 
factors embodied in the primary tumor, the biological 
importance of involved and uninvolved lymph nodes, 
the tumor-host interactions, and many other factors 
which, to a great extent, determine the outcome after 
employing any of the accepted surgical and combined 
therapeutic regimens (11-15). 
To provide answers to many questions in this contro-
versy, prospective randomized clinical trials among 
cooperative groups and academic institutions have been 
in progress for the past twenty years. The model for such 
studies is the National Surgical Adjuvant Breast Project 
(NSABP) under the guidance and coordinat ion of Dr. 
Bernard Fisher. The opposing points of view about 
mastectomy and its variations and the combined treat-
ment regimens, as they were expressed in the 1950s and 
1960s, have been summarized in an American Cancer 
Society publication entit led "Updated Breast Cancer" 
(16) and by Fisher in 1970 in "Current Problems In 
Surgery" (17). 
In the 1980s, surgical attitudes have become more 
f lexible, and new approaches and ideas are more readily 
accepted. This change has come about partly because 
new information about the biology of breast cancer (10) 
is now available, because prognostic factors in the tumor 
and host (11,13,14) mandating selective use of local or 
systemic treatment are better understood, and partly 
because control led clinical trials have reported on thera-
peutic regimens judged for their effectiveness outside of 
selective settings (10). 
To an equally great extent, the change in surgical 
attitudes is due to the change in the breast cancer profi le 
(8). Through mass detect ion, breast screening, mam-
mograms, and the accompanying publicity, breast can-
cers are found earlier, and primary tumors are easier to 
control . For these reasons, the incidence of axillary node 
metastases has decreased in the past ten years (10-15,18-
19). The prevailing surgical approaches in the treatment 
of breast cancer in the United States incorporate most of 
this new information (8,20), which has been summarized 
by Urban (8) and by Kinne (20). These authors emphasize 
the effectiveness of total mastectomy and axillary lymph-
adenectomy as "adequate" local-regional therapy and 
stress the need for adjuvant systemic therapy in patients 
with high-risk features. They also emphasize the need to 
avoid undertreating patients in high-risk categories. 
Through the use of adequate local-regional therapy 
and adjuvant treatment, 98% of patients with minimal 
breast cancers and 70-80% of those presenting in Stage I 
are free of disease at ten years. Table I summarizes some 
selected, representative series of patients treated surgi-
cally and lists the respective results at five and ten years, 
as reported over a twenty-year period (1963-1983). 
The third area of controversy in the 1950s was the role of 
radiation therapy for patients with early breast cancer 
who were treated by radical or modi f ied radical 
mastectomy. Most arguments supported the use of 
TABLE I 
Five- and Ten-Year Results of Radical Mastectomy (Selected Series) 
No Evidence of Disease % of Local 
Author Stage No. of Patients 5 Years 10 Years Recurrence 
Haagensen(22) A 344 84 
Haagensen(23) A 710 70,6 6,2 
(New York) B 198 44,0 18,0 
Urban(7) 1 342 82 71 7.7 
(New York) 11 292 50 28 
Fracchia(15) T2, No 554 84.6-75,7 76.9-68,5 
(New York) T l , T 2 , N i 
1 
748 65,6-38,0 47,3-26,7 
Romsdahl(24) 203 88 80 4.4 
(Houston) II 332 67 58 8.4 
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radiotherapy as an adjuvant to surgical treatment for 
patients with positive nodes, large carcinomas, or lesions 
located in the central or median sectors of the breast. 
The treatment, which was directed at the lymphatic bed 
and the chest wal l , was viewed as an extension of the 
radical mastectomy for the eradication of microscopic 
disease at surgically inaccessible sites and in the chest 
wall. In the 1950s, radiotherapy was also used as def in i -
tive treatment for patients with incurable or inoperable 
breast cancers due to local reasons (2,3). As adjuvant 
chemotherapy developed in the 1960s and 1970s, how-
ever, and as controversial reports of the efficacy of 
radiation increased (18), the role of adjuvant radio-
therapy diminished. Some of the opposing views were 
summarized in "Updated Breast Cancer" (16) and more 
recently by Henderson and Canellos (18) and by M o n -
tague and Fletcher (21). While opinions vary as to the 
value of postoperat ive adjuvant radiotherapy after 
mastectomy and lymphadenectomy, its role in decreasing 
local-regional recurrences has been well accepted, and 
some evidence indicates that it is associated with better 
survival at five and ten years (21). 
The Current Controversy 
The first serious challenge to the radical mastectomy 
from outside surgical groups appeared in 1948 when 
McWhi r te r (25,26) reported that results of treating 
breast cancer by simple mastectomy and orthovoltage 
radiotherapy were comparable to those obtained by 
radical mastectomy. This challenge involved treating the 
lymph nodes rather than the breast, but because of 
unacceptable complications and inferior results when 
compared to the best surgical series (23), the approach 
never found wide acceptance, at least in the United 
States. Nevertheless, when compared to other treatment 
regimens retrospectively as well as prospectively, the 
results were comparable (18). 
The major challenge, however, to treating breast 
cancer by mastectomy and lymphadenectomy has de-
veloped in the past ten years. Based on a number of 
retrospective observations (24,27-32), the challenge has 
been strengthened by recent reports of prospective ran-
domized trials (33) in which supervoltage radiation 
therapy has been the primary therapeutic modality after 
biopsy or only local excision of the primary tumor. The 
entire breast, the chest wall, and the lymphatic drainage 
area are treated by supervoltage radiation, with booster 
doses added to the site of the original tumor for better 
control . The axillary lymph nodes may be left undis-
turbed, biopsied, "sampled," or completely removed. 
Radiotherapy to the axilla varies, although most authors 
suggest that if the biopsied nodes are negative or if they 
have been completely excised, radiotherapy to the axilla 
is not needed. As early as the late 1930s, Baclesse in 
France (27) showed that adequate radiation therapy was 
capable of sterilizing breast cancers histologically. Be-
cause of the prolonged t ime of treatment, however, and 
the serious local side effects and sequelae, orthovoltage 
radiotherapy found limited acceptance as a primary 
treatment modality. With the advent of supervoltage 
technology, local side effects were reduced, and cos-
metic results improved. Also, radiation therapy in place 
of mastectomy became more popular in Europe (27,29) 
and found l imited acceptance in Canada (30). In the 
United States, its use was reserved for patients medically 
unsuitable for mastectomy, those refusing the opera-
t ion, and those with inoperable or locally advanced 
breast cancers (24,28,31,32). The sporadic reports of the 
1950s and 1960s (16) became more frequent in the 1970s 
(31,32). The results were appropriately publicized (19,34) 
and eventually captured the attention of the medical 
profession as well as the public (35). 
This evolut ion occurred at the same t ime as many 
other changes took place in the breast cancer field (20): 
outpatient breast biopsy, the two-stage approach to 
breast cancer treatment, exploration of treatment alter-
natives, and patient participation in selecting treatment. 
Much of the information about primary radiotherapy 
was derived f rom a host of variable data, including totally 
different practice details, dissimilar staging systems that 
made comparisons diff icult, and variations in surgical 
and radiotherapeutic technique. In the ensuing con-
fusion, emotionalism about breast preservation has oc-
casionally overshadowed some of the facts about the 
effectiveness of local and regional control of the cancer 
process, the associated morbidi ty, the need for salvage 
mastectomy, and the acceptability of cosmetic results. 
In 1978, Calle (27) reported excellent five- and ten-
year results with primary radiotherapy for tumors less 
than 3 cm in diameter but wi th 13% local failure and with 
28% minimal and 27% moderate, radiation-related 
sequelae. Among large tumors, the local recurrence rate 
was 19%; salvage mastectomy was needed in 55% of the 
cases, and 8 1 % of the breasts removed had persistent 
cancer. Amalric, et al (29) reported that 24% of patients 
treated conservatively required salvage mastectomy 
with in five years and 32% in ten years; and, at secondary 
surgery, 76% of the patients had residual carcinoma. 
Clark, et al (30) observed a 12.3% relapse in the treated 
breast wi th in five years and 21.5% in ten years. While the 
results at five and ten years for small carcinomas and 
negative axillary nodes appeared excellent, there were 
obvious concerns about the fate of patients with more 
advanced lesions. Equally important were concerns 
about the fate of those patients whose breast cancer has 
been treated successfully but who are in need of life-
long fo l low-up for progressively advancing radiation 
effects and sequelae. Indeed, Clark (30) advocated bal-
ancing the amount of radiation therapy for opt imal, not 
maximal, results in order to avoid treatment-related 
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complications. The implications of such an approach for 
potential undertreatment are obvious. Five- and ten-
year results of selective retrospective series of such 
methods are shown in Table II. 
The greatest impetus to the use of primary radio-
therapy and breast preservation was provided in 1981 by 
Veronesi, et al (34), who reported results of a ran-
domized prospective clinical trial at the Cancer Institute 
of Mi lan, Italy. The report was based on 701 evaluable 
patients in whom quadrantectomy, axillary node dissec-
t ion, and radiotherapy to the breast were compared to 
standard or modif ied radical mastectomies. All patients 
had invasive cancers less than 2 cm in diameter (Tq), and 
the axillary nodes were negative to palpation (NQ, 
clinical). With 350 patients in each arm of the study, 
appropriately stratified for age, menopausal status, prior 
biopsy, and histologically verified axillary node metas-
tases, median fo l low-up of four years disclosed that 
overall survival and disease-free survival were identical 
for both treatment regimens. Al though a four-year 
fo l low-up in breast cancer is short, the trends in that 
study are convincing. As a result, enthusiasm for breast-
preserving treatment methods has increased. 
Studies f rom North America and Europe dealing with 
breast preservation and primary radiotherapy for cancer, 
both retrospective and prospective, were reviewed in 
1982 at an international symposium (36). While the thrust 
of the symposium was to compile data in support of 
alternatives to mastectomy, the proceedings reflected 
the unusual variability, both in the United States and 
abroad, of patient selection, techniques, and assessment 
of results. Still at issue are the management of axillary 
lymph nodes, frequency of fo l low-up, ability to ade-
quately assess the treated breast to detect new or 
residual cancer, radiotherapy-related complications, in -
cluding potential carcinogenic effects to the untreated 
breast and other organs. 
Discussion 
It is obvious f rom this brief review that l imited surgery 
with breast preservation and radiotherapy has been most 
effective in treating patients with Stage I (TTNQ) breast 
cancers. In return for breast preservation, a l i fe-long 
concern remains about local recurrence, new cancers in 
the treated breast, increased cancer incidence in the 
untreated breast, radiation sequelae to the underlying 
soft tissues and bony structures, and unknown risk for 
new cancers in the treated f ield. While adequate local-
regional surgical treatment accomplishes at least as 
good or better results wi thout similar concerns, the 
physical and psychological price of loss of the breast 
is high. For cancers in the more advanced stages (Stage II -
TABLE II 
Five- and Ten-Year Results of Breast Preservations 
and Radiotherapy (Selecled Series) 
Breast Preserved 
NED* % Local (% of Survivors 
Author Stage No Pts 5 Yr 10 Yr Rec 5 Yr 10 Yr 
Calle(27) T<3cmNo 120 85 75 1 1 % 94 88 
(Paris) T > 3 N O N T 394 68 4 i 14% 55 54 
Total 514 72 51 58 61 
Amalric(20) 1 559 76 74 20% 88 84 
(Marseilles) 11 540 61 56 75 64 
III 341 37 30 J V . D / o 61 46 
Total 1440 61 56 79 71 
Clark(30) T l J l s 316 8 ! 63 12,3%- 80? 
(Toronto) T2,Tx 327 73 60 21,5% 
Other 37 
Total 680 83 71 
Pierquin(36) T l 99 84 65 7% 87 
(Cretei l , France) T2 235 75 64 15% 54 
T3 74 65 45 
Harris(32) I 94 85 9";. 
(Boston) II 172 75 
Montague(36) 1 103 86 78 6.8% 
(Houston) 11 122 66 60 4.9% 
•No Evidence of Disease 
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T 2 N O , T T N - I , T 2 N T ) , mastectomy and adjuvant therapy is 
better than breast-preserving procedures, which are as-
sociated with a higher incidence of local-regional failure, 
with a frequent need for salvage mastectomy, and with 
radiation-related morbidity (24,26-29). Achieving results 
comparable to or better than surgery by using breast 
preservation and radiotherapy approaches requires ab-
solute quality control of the radiotherapeutic tech-
niques. Since treatment locations and professional and 
technical personnel vary widely, results obtained at the 
best centers may prove diff icult to duplicate country-
wide, and radiation-related effects may vary f rom those 
already reported. Thus, the concerns expressed in the 
1982 meeting (36) may prove to be understated after the 
results of longer fo l low-up become known. 
The extent of operation necessary for optimal breast-
preserving treatment has not been standardized. Some 
variables to be considered with the primary tumor 
include lumpectomy, quadrantectomy, incisional biopsy, 
use of frozen sections on margins, location of incisions to 
give the best cosmetic results, and nipple-areola man-
agement in central lesions. The extent of surgery in the 
axilla is also a controversial issue. Complete dissection, 
simple biopsy, or sampling of several lymph nodes (over 
five) are some recommended approaches. These details 
inf luence the extent of the f ield and the amount of 
radiotherapy needed to control cancer, the anticipated 
complications, and the cosmetic results achieved. A l -
though well-planned and executed breast-preserving 
approaches have a cosmetic advantage over mastec-
tomy, the perception of the procedure as a simple, 
minor operation wil l adversely affect surgical quality 
control and allow for more variable results. Further-
more , in cases requ i r ing salvage mastectomy, the 
cosmetic results after the second procedure are 
compromised, and morbidity is of increased concern. 
These considerations are important since 30% to 60% of 
patients with Stage II cancers treated at expert centers 
have required salvage mastectomy over a five-year 
fo l low-up period (27,29). 
While these concerns are well understood by those 
w o r k i n g in the special ized f ields of surgery and 
radiation therapy (36), they are often inadequately 
discussed and poorly appreciated by patients. Occasion-
ally, these concerns are altogether disregarded in the 
emotion-laden period immediately after diagnosis, when 
a rational plan of optimal treatment needs to be fo rmu-
lated. Thus, breast preservation at all costs overrides the 
best treatment plans in many instances, regardless of 
age, anatomical details which preclude good cosmetic 
results, or mammographic anatomic and biological evi-
dence favoring total mastectomy. The dilemma of bal-
ancing equally effective or proven superior therapy for 
cancer to that prompted by cosmetic and psychological 
considerations has made surgeons in the United States 
reluctant to recommend breast preservation procedures 
indiscriminately. However, American surgeons are 
heeding the message that "some of the answers are i n " 
(37), and they remain open to additional information. 
TABLE III 
Some Advantages and Disadvantages of Mastectomy and Axil lary 
Lymphadenectomy for Early Breasl Cancers (TNM Stages I and II) 
Advantages Disadvantages 
1, Complete removal of tissue at 1, Physical deformity, 
2. Psychological impact, 
2, Better tissue study (mul t i - _ ^ , , , 3, Surgical morbid i ty-
centric Ca, in situ Ca , ., , 
complications, 
3, Better study and treatment of , . , . , , 
, , 4, Arm lymphedema and lymph nodes, , 
sequelae, 
4, Better staging and treatment ,- „ L • _i 
, , 5, Prosthetic and reconstruction planning, problem and expenses, 
5, Less anxiety about local re-
currence, radiation side 
effects, opposite breast 
risk, 
6, Treatment completed in a 
short per iod of t ime, 
7, Less expensive (?), 
8, Ample informat ion of results 
up to 30 years, 
9, Better local-regional contro l 
for Stage II and 111 cancers. 
In formulat ing therapeutic recommendations, it is 
necessary to consider the best information available 
about breast preservation operations and radiotherapy 
asan alternative to mastectomy, to weigh the advantages 
and disadvantages of each procedure, and to match the 
therapeutic approach to the patient with cancer. With 
such an approach, patient-related risk factors, tumor-
associated risk factors, t ime and cost of each treatment, 
and fo l low-up aspects can be discussed, and the phy-
sician's recommendation can be made objectively. The 
patient, better informed of the alternatives, the asso-
ciated risks, and shortcomings, wil l then beable to join in 
the best decision for her treatment. Tables 111 and IV list 
some of the advantages and disadvantages of each 
approach and current concerns. Of necessity, such lists 
must remain tentative for several years. As experience 
accumulates and as the controversy is tested through 
randomized clinical trials, the effectiveness and appli-




From currently available information the fol lowing 
principles seem reasonable: 
1. Modi f ied radical mastectomy is considered to 
be the optimal surgical treatment for Stage I 
( T I N Q M O ) breast cancer in the United States. 
2. Radiotherapy and breast-preserving proce-
dures are probably equally effective in the 
treatment of Stage I breast cancers; however, 
longer fo l low-up periods are needed to sub-
stantiate this content ion. 
3. Selection of breast-preservation approaches 
is made for cosmetic and psychological rea-
sons, not for reasons of superior results. 
4. Patients w i th non invas ive, mu l t i cen t r i c , 
bilateral, and familial breast cancers are not 
considered good candidates for breast-pre-
serving approaches. 
5. Modi f ied radical mastectomy is presently con-
sidered superior to treat Stage II (T2N0, T^t^^, 
T 2 N T ) breast cancers. Failures are usually due 
to systemic metastases, and adjuvant chemo-
therapy represents the best hope for improv-
ing results. 
6. When radiotherapy is used as a primary 
modality for treating Stage II breast cancers, 
the incidence of local-regional failure is high, 
and salvage mastectomy is needed in 30% to 
60% of patients; results are equivocal; and 
there are considerable side effects and radi-
ation-related complications. In such instances 
salvage mastectomy negates the reason for 
the initial selection. 
7. To maximize cancer control and cosmetic 
results in breast-preserving approaches, there 
is great need for patient selection and stan-
dardization of the surgical as well as the radio-
therapeuticdetails. Thisstandardization is not 
yet available. 
TABLE IV 
Some Advantages and Disadvantages of Breast Preservation 
Procedures and Primary Radiotherapy for Early Breast Cancers 
(TNM Stages I and II) 
Advantages 
1, Better cosmetic results in 
most instances, 
2, Probably effective in local-
regional contro l of Stage I 
cancers, 
3, Less arm edema in axillary 
treatment, 
4, Psychological advantage: 
body image preserved, 
5, May contr ibute to seeking 
earlier treatment. 
Disadvantages 
1, Continues to involve surgical 
procedures, 
2, Treatment not standard at 
present, 
3, Local-regional contro l in 
Stage II and III carreers 
inferior, 
4, Need for salvage mastectomy 
over t ime. 
5, Prolonged and expensive 
therapy, 
6, Local-regional concern for 
the rest of the patient's life. 
7, Risk for opposite breast 
cancer higher? 
8, Long-term radiation effects? 
9, Radiation side effects 
considerable, 
10. Cosmetic results not always 
achieved. 
11, Lymph node assessment not 
always adequate, 
12. Interferes wi th adjuvant 
chemotherapy. 
13, Indications and selection 
process not clear at present. 
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